🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This investigator-initiated study will compare ADM and resorbable cross-lin...
Status
Not Yet Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-10
Trial ID
NCT07613047
The purpose of the study is to evaluate whether clinical parameters for Pur...
Status
Completed
Location
University of Alabama
Start Date
2009-08
Trial ID
NCT00881959
Treatments Being Tested
The purpose of this study is to compare two ways of caring for wounds after...
Status
Not Yet Recruiting
Location
Baylor University Medical Center
Start Date
2026-06
Trial ID
NCT07587749
Treatments Being Tested
This research study will evaluate the effectiveness of high dose UVB light ...
Status
Completed
Location
University of Michigan Department of Dermatology
Start Date
2002-08
Trial ID
NCT00129428
Treatments Being Tested
Minimally invasive procedures with the tunnel technique have been suggested...
Status
Completed
Location
Giuseppe D'Albis
Start Date
2021-01-01
Trial ID
NCT05475730
Treatments Being Tested
The study will examine the effectiveness of a decellularized dermal matrix ...
Status
Not Yet Recruiting
Location
Northwestern Ontario (NWO) Wound Care Centre of Excellence
Start Date
2024-12-30
Trial ID
NCT05251480
Treatments Being Tested
The goal of this study is to evaluate safety and performance of the Fortiva...
Status
Enrolling By Invitation
Location
James Paget University Hospital
Start Date
2023-11-15
Trial ID
NCT06101979
Treatments Being Tested
Currently the two-stage tissue expander/implant (TE/I) technique is the sta...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2009-09-01
Trial ID
NCT00956384
Treatments Being Tested
The purpose of this study is to evaluate the esthetic outcomes following im...
Status
Completed
Location
The University of Texas Health Science Center at Houston
Start Date
2016-10
Trial ID
NCT02864862
Treatments Being Tested
MIROCALS is a phase II study of ld-IL-2 as a therapeutic agent for ALS. A r...
Status
Completed
Location
CHRU de Lille - Hôpital Roger Salengro
Start Date
2017-06-19
Trial ID
NCT03039673
Treatments Being Tested